Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease | Zendy

Sonia S. Anand | Zendy; Salim Yusuf | Zendy; Changchun Xie | Zendy; Janice Pogue | Zendy; John W. Eikelboom | Zendy; Andrzej Budaj | Zendy; Bruce Sussex | Zendy; Lisheng Liu | Zendy; Randolph Guzman | Zendy; Claudio S. Cinà | Zendy; Richard Crowell | Zendy; Matyàs Keltai | Zendy; Gilbert Gosselin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease

Author(s) -

Sonia S. Anand,

Salim Yusuf,

Changchun Xie,

Janice Pogue,

John W. Eikelboom,

Andrzej Budaj,

Bruce Sussex,

Lisheng Liu,

Randolph Guzman,

Claudio S. Cinà,

Richard Crowell,

Matyàs Keltai,

Gilbert Gosselin

Publication year - 2007

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa065959

Subject(s) - medicine , myocardial infarction , stroke (engine) , cardiology , vascular disease , coronary artery disease , relative risk , infarction , confidence interval , mechanical engineering , engineering

Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research